Drug Shortage Report for TARO-RISPERIDONE
Report ID | 199146 |
Drug Identification Number | 02328313 |
Brand name | TARO-RISPERIDONE |
Common or Proper name | RISPERIDONE |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 0.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-05-12 |
Estimated end date | 2023-09-15 |
Actual end date | 2023-09-15 |
Shortage status | Resolved |
Updated date | 2023-09-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-09-22 | French | Compare |
v9 | 2023-09-22 | English | Compare |
v8 | 2023-09-22 | French | Compare |
v7 | 2023-09-22 | English | Compare |
v6 | 2023-08-30 | French | Compare |
v5 | 2023-08-30 | English | Compare |
v4 | 2023-08-16 | French | Compare |
v3 | 2023-08-16 | English | Compare |
v2 | 2023-07-18 | French | Compare |
v1 | 2023-07-18 | English | Compare |
Showing 1 to 10 of 10